上一年急性加重次数是否应指导COPD治疗?
该研究基于ECLIPSE和SPIROMICS两个大型队列,用贝叶斯模型分析发现COPD患者存在稳定的个体特异性急性加重基础速率,但基于观察到的年加重次数定义的频繁加重表型因随机性而不稳定,两年间分类变化可超过30%,因此质疑其用于指导治疗决策的适宜性。
要点
- COPD患者存在稳定的个体特异性AECOPD基础速率。
- 观察到的年加重次数波动大,频繁加重表型不稳定。
- 基于既往AECOPD次数指导治疗决策的适宜性存疑。
核心结论
- COPD患者 underlying AECOPD rate 是稳定特质,但基于观察AECOPD模式的频繁加重表型不稳定,其指导治疗决策的适宜性应受质疑。
- 需评估更长持续时间或使用多变量预测模型能否获得更稳定的表型。
研究设计与样本
- 时间-事件分析原理阐述频繁加重表型变异的两个来源: underlying AECOPD rate 变异和个体AECOPD发生的随机性。
- 重新分析ECLIPSE和SPIROMICS两个大型队列数据,使用贝叶斯模型分离变异来源。
主要发现
- 两个队列中AECOPD模式均强烈支持存在个体特异性且随时间稳定的 underlying AECOPD rate(Bayes Factor小于0.001)。
- 个体患者观察到的AECOPD率年际间可显著变化。
- 对于 underlying rate 为0.8-3.1 events·year-1者,基于观察率的频繁加重分类在连续两年间因偶然性变化超过30%。
- 对于 underlying rate 为1.2-2.2 events·year-1者,该变化值增至超过45%。
临床怎么用
- 临床不应仅凭上一年AECOPD次数判定频繁加重表型并据此制定治疗。
- 考虑结合更长观察期或多变量预测模型评估COPD加重风险。
局限性
- 研究为对既有队列数据的再分析,未报告新的前瞻性验证。
- 更长观察期或多变量模型能否获得更稳定表型尚待评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In contemporary management of chronic obstructive pulmonary disease (COPD), the frequent exacerbator phenotype, based on a 12-month history of acute exacerbation of COPD (AECOPD), is a major determinant of therapeutic recommendations. However, there is considerable debate as to the stability of this phenotype over time. METHODS: We used fundamental principles in time-to-event analysis to demonstrate that variation in the frequent exacerbator phenotype has two major sources: variability in the underlying AECOPD rate and randomness in the occurrence of individual AECOPDs. We re-analysed data from two large cohorts, the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study and the SubPopulations and InteRmediate OutcoMes In COPD Study (SPIROMICS), using a Bayesian model that separated these sources of variability. We then evaluated the stability of the frequent exacerbator phenotype based on these results. RESULTS: In both cohorts, the pattern of AECOPDs strongly supported the presence of an individual-specific underlying AECOPD rate which is stable over time (Bayes Factor less than 0.001). Despite this, the observed AECOPD rate can vary markedly year-to-year within individual patients. For those with an underlying rate of 0.8-3.1 events·year-1, the frequent exacerbator classification, based on the observed rate, changes more than 30% of the time over two consecutive years due to chance alone. This value increases to more than 45% for those with an underlying rate of 1.2-2.2 events·year-1. CONCLUSIONS: While the underlying AECOPD rate is a stable trait, the frequent exacerbator phenotype based on observed AECOPD patterns is unstable, so much so that its suitability for informing treatment decisions should be questioned. Whether evaluating AECOPD history over longer durations or using multivariate prediction models can result in more stable phenotyping needs to be evaluated.
引用
- Sadatsafavi M, McCormack J, Petkau J, et al. Should the number of acute exacerbations in the previous year be used to guide treatments in COPD? Eur Respir J. 2021. PMID: 32855228. doi:10.1183/13993003.02122-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。